Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: A multicenter countrywide study

Yilmaz N., KARADAĞ Ö., Kimyon G., YAZICI A., YILMAZ S., KALYONCU U., ...Daha Fazla

EUROPEAN JOURNAL OF RHEUMATOLOGY, cilt.1, sa.2, ss.51-54, 2014 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 1 Sayı: 2
  • Basım Tarihi: 2014
  • Doi Numarası: 10.5152/eurjrheumatol.2014.018
  • Dergi Adı: EUROPEAN JOURNAL OF RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.51-54
  • Anahtar Kelimeler: Hepatitis, rheumatoid arthritis, ankylosing spondylitis
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Objective: Immunosuppressive therapies, especially tumor necrosis factor-a inhibitors, are frequently used in treatment of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). These therapies can induce viral reactivation in concurrent hepatitis B virus (HBV)- or hepatitis C virus (HCV)positive patients. On the other hand, the prevalence of HBV and HCV infections is not exactly known in RA and AS patients. The aim of this study was to investigate the prevalence of HBV and HCV infections in RA and AS patients.